FdaApplication
NDA 210854
Identifiers
- fda_app_no: NDA210854
Properties
| Property | Value |
|---|---|
| applicant_name | GENENTECH INC |
| application_type | NDA |
| approval_date | 2018-10-24 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XOFLUZA | BALOXAVIR MARBOXIL | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| XOFLUZA | BALOXAVIR MARBOXIL | 40MG | TABLET;ORAL |
| XOFLUZA | BALOXAVIR MARBOXIL | 80MG | TABLET;ORAL |
3 products